Table 3 Adjusted means for health-related outcomes at 3 and 12-monthsa
Variable | N | Intervention | Control | Difference (90% CI) |
|---|---|---|---|---|
Body mass (kg) | ||||
3 months | 188 | 84.1 | 84.3 | −0.2 (−1.0 to 0.5) |
12 months | 186 | 83.6 | 84.4 | −0.8 (−1.8 to 0.2) |
Body mass index (kg/m2) | ||||
3 months | 188 | 28.6 | 28.7 | −0.1 (− 0.3 to 0.1) |
12 months | 186 | 28.5 | 28.8 | −0.3 (− 0.6 to 0.04) |
Waist circumference (cm) | ||||
3 months | 188 | 98.3 | 98.0 | 0.3 (−0.6 to 1.2) |
12 months | 186 | 99.2 | 99.0 | 0.2 (−1.2 to 1.5) |
Total body fat (%) | ||||
3 months | 165 | 32.6 | 32.5 | 0.1 (−0.4 to 0.6) |
12 months | 166 | 32.4 | 32.7 | −0.3 (− 0.8 to 0.3) |
Visceral body fat (cm2) | ||||
3 months | 165 | 180.4 | 183.1 | −2.7 (− 8.8 to 3.4) |
12 months | 166 | 186.9 | 193.1 | −6.2 (− 13.8 to 1.4) |
Fat mass index (kg/m2) | ||||
3 months | 165 | 9.3 | 9.3 | 0.0 (−0.2 to 0.2) |
12 months | 166 | 9.3 | 9.5 | −0.2 (− 0.4 to 0.1) |
SBP (mmHg) | ||||
3 months | 188 | 129 | 130 | −1 (−5 to 3) |
12 months | 186 | 133 | 133 | 0 (−3 to 3) |
DBP (mmHg) | ||||
3 months | 188 | 83 | 85 | −2 (−4 to 0) |
12 months | 186 | 82 | 83 | −1 (−3 to 1) |
Glucose (mmol/L) | ||||
3 months | 188 | 5.1 | 5.1 | 0.0 (−0.1 to 0.1) |
12 months | 183 | 5.1 | 5.2 | −0.1 (− 0.2 to 0.0) |
Insulin (mU/L)b | ||||
3 months | 183 | 65.8 | 68.3 | −2.5 (−8.7 to 4.0) |
12 months | 181 | 72.2 | 71.7 | 0.5 (−7.9 to 9.6) |
HOMA-IRb | ||||
3 months | 183 | 2.2 | 2.2 | 0.0 (−0.3 to 0.2) |
12 months | 177 | 2.4 | 2.4 | 0.0 (−0.4 to 0.3) |
Total cholesterol (mmol/L) | ||||
3 months | 188 | 5.6 | 5.7 | −0.1 (− 0.2 to 0.1) |
12 months | 184 | 5.7 | 5.8 | −0.1 (− 0.3 to 0.05) |
LDL cholesterol (mmol/L) | ||||
3 months | 188 | 3.4 | 3.4 | 0.0 (−0.2 to 0.2) |
12 months | 184 | 3.4 | 3.5 | −0.1 (− 0.2 to 0.1) |
HDL cholesterol (mmol/L) | ||||
3 months | 188 | 1.6 | 1.6 | 0.0 (−0.06 to 0.04) |
12 months | 184 | 1.6 | 1.6 | 0.0 (−0.1 to 0.03) |
Triglycerides (mmol/L)b | ||||
3 months | 188 | 1.4 | 1.5 | −0.1 (− 0.25 to 0.03) |
12 months | 184 | 1.4 | 1.5 | −0.1 (− 0.2 to 0.1) |
CRP (mg/l)b | ||||
3 months | 186 | 2.5 | 3.3 | −0.8 (− 1.5 to − 0.1) |
12 months | 183 | 3.2 | 3.1 | 0.1 (−0.7 to 0.9) |
CVD risk: 10-year risk (%)b | ||||
3 months | 188 | 14.0 | 14.0 | 0.0 (−0.5 to 0.5) |
12 months | 186 | 15.0 | 14.9 | 0.1 (−0.5 to 0.7) |
Diabetes risk: 10-year risk (%)b | ||||
3 months | 188 | 12.8 | 13.0 | −0.2 (− 0.7 to 0.3) |
12 months | 186 | 12.9 | 13.6 | −0.7 (−1.5 to 0.02) |
EQ-5D | ||||
3 months | 184 | 77.4 | 74.3 | 3.1 (0.0 to 6.2) |
12 months | 186 | 75.7 | 72.4 | 3.3 (−1.4 to 8.2) |